Porter K - Search Results

1

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.

Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, Phillips A, Porter K; CASCADE Collaboration. Bhaskaran K, et al. Among authors: porter k. Ann Neurol. 2008 Feb;63(2):213-21. doi: 10.1002/ana.21225. Ann Neurol. 2008. PMID: 17894380

2

Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters.

Babiker A, Darbyshire J, Pezzotti P, Porter K, Prins M, Sabin C, Walker AS; CASCADE Collaboration. Babiker A, et al. Among authors: porter k. J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):303-10. doi: 10.1097/00126334-200303010-00010. J Acquir Immune Defic Syndr. 2003. PMID: 12626891

3

Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.

Bhaskaran K, Brettle R, Porter K, Walker AS; CASCADE Collaboration. Bhaskaran K, et al. Among authors: porter k. AIDS. 2004 Mar 5;18(4):673-81. doi: 10.1097/00002030-200403050-00012. AIDS. 2004. PMID: 15090773

4

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K; CASCADE Collaboration. Bhaskaran K, et al. Among authors: porter k. JAMA. 2008 Jul 2;300(1):51-9. doi: 10.1001/jama.300.1.51. JAMA. 2008. PMID: 18594040

5

CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era.

Lodi S, Phillips A, Touloumi G, Pantazis N, Bucher HC, Babiker A, Chêne G, Vanhems P, Porter K; CASCADE Collaboration. Lodi S, et al. Among authors: porter k. AIDS. 2010 Nov 13;24(17):2697-704. doi: 10.1097/QAD.0b013e32833ef6c4. AIDS. 2010. PMID: 20885283

6

HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.

UK Collaborative HIV Cohort (CHIC) Study Steering Committee; Garvey L, Winston A, Walsh J, Post F, Porter K, Gazzard B, Fisher M, Leen C, Pillay D, Hill T, Johnson M, Gilson R, Anderson J, Easterbrook P, Bansi L, Orkin C, Ainsworth J, Phillips AN, Sabin CA. UK Collaborative HIV Cohort (CHIC) Study Steering Committee, et al. Among authors: porter k. Eur J Neurol. 2011 Mar;18(3):527-34. doi: 10.1111/j.1468-1331.2010.03291.x. Epub 2010 Dec 15. Eur J Neurol. 2011. PMID: 21159073

7

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Porter K, Walker AS; CASCADE Collaboration. Porter K, et al. Lancet. 2003 Oct 18;362(9392):1267-74. doi: 10.1016/s0140-6736(03)14570-9. Lancet. 2003. PMID: 14575971

8

Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters.

Bhaskaran K, Pillay D, Walker AS, Fisher M, Hawkins D, Gilson R, McLean K, Porter K; UK Register of HIV Seroconverters. Bhaskaran K, et al. Among authors: porter k. AIDS. 2004 Jul 2;18(10):1471-3. doi: 10.1097/01.aids.0000131341.45795.33. AIDS. 2004. PMID: 15199326

9

The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.

Smith CJ, Phillips AN, Hill T, Fisher M, Gazzard B, Porter K, Gilson R, Easterbrook P, Matthias R, Scullard G, Johnson MA, Sabin CA; United Kingdom Collaborative HIV Cohort Study Group. Smith CJ, et al. Among authors: porter k. J Infect Dis. 2005 Oct 15;192(8):1387-97. doi: 10.1086/466534. Epub 2005 Sep 14. J Infect Dis. 2005. PMID: 16170756

10

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.

Touloumi G, Pantazis N, Antoniou A, Stirnadel HA, Walker SA, Porter K; CASCADE Collaboration. Touloumi G, et al. Among authors: porter k. J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):554-61. doi: 10.1097/01.qai.0000230321.85911.db. J Acquir Immune Defic Syndr. 2006. PMID: 16868497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,947 results

Search Page